» Articles » PMID: 27743072

Adverse Effects of Anastomotic Leakage on Local Recurrence and Survival After Curative Anterior Resection for Rectal Cancer: A Systematic Review and Meta-analysis

Overview
Journal World J Surg
Publisher Wiley
Specialty General Surgery
Date 2016 Oct 16
PMID 27743072
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Anastomotic leakage is a serious complication associated with anterior resection for rectal cancer, the long-term effects of which are unclear. Therefore, a systematic review and meta-analysis were conducted to evaluate the impact of anastomotic leakage on disease recurrence and survival.

Methods: We searched PubMed, Embase, and the Cochrane Library databases from their inception to January 2016. Studies evaluating the oncologic impact of anastomotic leakage were included in the meta-analysis. Outcome measures were local recurrence, overall survival, cancer-specific survival, and distant recurrence. Pooled hazard ratio (HR) with 95 % confidence interval (CI) was calculated using random effects models.

Results: Fourteen studies containing 11,353 patients met inclusion criteria. Anastomotic leakage was associated with a greater local recurrence (HR 1.71; 95 % CI 1.22-2.38) and decreased in both overall survival (HR 1.67; 95 % CI 1.19-2.35) and cancer-specific survival (HR 1.30; 95 % CI 1.08-1.56); anastomotic leakage did not increase distant recurrence (HR 1.03; 95 % CI 0.76-1.40).

Conclusions: Anastomotic leakage was associated with high local recurrence and poor survival (both overall and cancer-specific), but not with distant recurrence.

Citing Articles

The role of adjuvant chemotherapy in rectal cancer: A nationwide cohort study from the Netherlands.

Darai A, Koeter T, van Erning F, van Alphen R, Verheul H, Verheij M Colorectal Dis. 2025; 27(3):e70054.

PMID: 40059308 PMC: 11891379. DOI: 10.1111/codi.70054.


Risk Factors for Anastomotic Leak in Patients Undergoing Surgery for Rectal Cancer Resection: A Retrospective Analysis.

Doniz Gomez Llanos D, Leal Hidalgo C, Arechavala Lopez S, Padilla Flores A, Correa Rovelo J, Athie Athie A Cureus. 2025; 17(2):e79647.

PMID: 40008105 PMC: 11857925. DOI: 10.7759/cureus.79647.


Comparison of the C-REX LapAid and Circular Stapled Colorectal Anastomoses in an Experimental Model.

Vilhjalmsson D, Gronberg A, Syk I, Thorlacius H Eur Surg Res. 2025; 66(1):9-17.

PMID: 39933492 PMC: 11892461. DOI: 10.1159/000543069.


Suspension and suturing technique can reduce the incidence of anastomotic leakage after rectal cancer excision: a single, prospective, cohort study.

Ge W, Shao L, Chen G, Qiu Y Sci Rep. 2024; 14(1):29197.

PMID: 39587181 PMC: 11589827. DOI: 10.1038/s41598-024-79800-6.


Physical pressure resistance of gastrointestinal anastomotic site via plate of polyglycolic acid promoting fibrosis.

Tanda H, Shibutani M, Natsuki S, Kasashima H, Fukuoka T, Maeda K Sci Rep. 2024; 14(1):26124.

PMID: 39478128 PMC: 11525944. DOI: 10.1038/s41598-024-77894-6.


References
1.
den Dulk M, Marijnen C, Collette L, Putter H, Pahlman L, Folkesson J . Multicentre analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgery. Br J Surg. 2009; 96(9):1066-75. DOI: 10.1002/bjs.6694. View

2.
Lin J, Yueh T, Chang S, Lin C, Lan Y, Wang H . The influence of fecal diversion and anastomotic leakage on survival after resection of rectal cancer. J Gastrointest Surg. 2011; 15(12):2251-61. DOI: 10.1007/s11605-011-1721-5. View

3.
Kang C, Halabi W, Chaudhry O, Nguyen V, Pigazzi A, Carmichael J . Risk factors for anastomotic leakage after anterior resection for rectal cancer. JAMA Surg. 2012; 148(1):65-71. DOI: 10.1001/2013.jamasurg.2. View

4.
Merkel S, Wang W, Schmidt O, Dworak O, Wittekind C, Hohenberger W . Locoregional recurrence in patients with anastomotic leakage after anterior resection for rectal carcinoma. Colorectal Dis. 2003; 3(3):154-60. DOI: 10.1046/j.1463-1318.2001.00232.x. View

5.
Nielsen H, Christensen I, Sorensen S, Moesgaard F, Brunner N . Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group. Ann Surg Oncol. 2000; 7(8):617-23. DOI: 10.1007/BF02725342. View